Winslow Garrett
SEC insider (Form 3/4/5 filer). CIK 0001803773. General Counsel at Damora Therapeutics, Inc. (DMRA). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in WALTHAM, MA.
Companies Winslow Garrett has filed insider reports for
- Damora Therapeutics, Inc. (DMRA): Officer, General Counsel
Winslow Garrett
CIK: 0001803773
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Damora Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 6, 2026DMRA
Damora Therapeutics, Inc.
SaleDirect245 shares at avg. $29.98$7K - Jul 3, 2026DMRA
Damora Therapeutics, Inc.
ExerciseDirect680 shares- - Mar 23, 2026DMRA
Damora Therapeutics, Inc.
AwardDirectStock Option (right to buy)
250K shares- - Jan 2, 2026GLTO
Galecto, Inc.
ExerciseDirect680 shares- - Jan 2, 2026GLTO
Galecto, Inc.
SaleDirect255 shares at avg. $21.38$5K - Jul 3, 2025GLTO
Galecto, Inc.
SaleDirect260 shares at avg. $3.39$881.4 - Jul 3, 2025GLTO
Galecto, Inc.
ExerciseDirect680 shares- - Jan 3, 2025GLTO
Galecto, Inc.
AwardDirectStock Option (right to buy)
6K shares- - Jan 3, 2025GLTO
Galecto, Inc.
ExerciseDirect1.3K shares- - Jan 3, 2025GLTO
Galecto, Inc.
SaleDirect471 shares at avg. $5.60$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 | DMRA Damora Therapeutics, Inc. | Sale | 245 | $29.98 | $7,345 | Direct |
| Jul 3, 2026 | DMRA Damora Therapeutics, Inc. | Exercise | 680 | - | $0 | Direct |
| Mar 23, 2026 | DMRA Damora Therapeutics, Inc. | Award Stock Option (right to buy) | 250,000 | - | - | Direct |
| Jan 2, 2026 |  GLTO Galecto, Inc. | Exercise | 680 | - | $0 | Direct |
| Jan 2, 2026 | GLTO Galecto, Inc. | Sale | 255 | $21.38 | $5,452 | Direct |
| Jul 3, 2025 | GLTO Galecto, Inc. | Sale | 260 | $3.39 | $881 | Direct |
| Jul 3, 2025 | GLTO Galecto, Inc. | Exercise | 680 | - | - | Direct |
| Jan 3, 2025 | GLTO Galecto, Inc. | Award Stock Option (right to buy) | 6,000 | - | - | Direct |
| Jan 3, 2025 | GLTO Galecto, Inc. | Exercise | 1,320 | - | $0 | Direct |
| Jan 3, 2025 | GLTO Galecto, Inc. | Sale | 471 | $5.60 | $2,638 | Direct |
1-10 of 11 transactions